The words listed below are used in this booklet, and likely to hear used by members of your healthcare team.
Adjuvant therapy or adjuvant treatment - Treatment given after the primary treatment to increase the chances of a cure. In cancer, adjuvant treatment often refers to chemotherapy, hormonal therapy or radiotherapy after surgery, which is aimed at killing any remaining cancer cells.
Advanced prostate cancer - Prostate cancer that has spread to surrounding tissue or has spread to other parts of the body.
Alternative therapy - Therapy used instead of standard medical treatment. Most alternative therapies have not been scientifically tested, so there is little proof that they work and their side effects are not always known.
Brachytherapy - A type of radiotherapy treatment that implants radioactive material sealed in needles or seeds into or near the tumour.
Cancer - A term for diseases in which abnormal cells divide without control.
Chemotherapy - The use of drugs, which kill or slow cell growth, to treat cancer. These are called cytotoxic drugs.
Clinical trial - Research conducted with the person’s permission, which usually involves a comparison of two or more treatments or diagnostic methods. The aim is to gain a better understanding of the underlying disease process and/or methods to treat it. A clinical trial is conducted with rigorous scientific method for determining the effectiveness of a proposed treatment.
Complementary therapy - Therapy used together with standard medical treatment. Examples include counselling, relaxation therapy, massage, acupuncture, yoga and meditation, aromatherapy, and art and music therapy.
Cultural engagement - Actively involve people with respect to their cultural needs.
Erectile dysfunction - Inability to achieve or maintain an erection firm enough for penetration.
External beam radiotherapy (EBRT) - Uses x-rays directed from an external machine to destroy cancer cells.
Fertility - Ability to have children.
Grade - A score that describes how quickly the tumour is likely to grow.
Hormone - A substance that affects how your body works. Some hormones control growth, others control reproduction. They are distributed around the body through the bloodstream.
Hormone therapy/treatment - Treatment with drugs that minimises the effect of testosterone in the body. This is also known as androgen deprivation therapy (ADT).
Incontinence - Inability to hold or control the loss of urine or faeces.
Locally advanced prostate cancer - Cancer which has spread beyond the prostate capsule and may include the seminal vesicles but still confined to the prostate region.
Lymph nodes - Also called lymph glands. Small, bean-shaped collections of lymph cells scattered across the lymphatic system. They get rid of bacteria and other harmful things. There are lymph nodes in the neck, armpit, groin and abdomen.
Metastatic prostate cancer - Small groups of cells have spread from the primary tumour site and started to grow in other parts of the body – such as bones.
Multidisciplinary care - A team approach to cancer treatment and planning.
Pelvic floor muscles - The floor of the pelvis is made up of muscle layers and tissues. The layers stretch like a hammock from the tailbone at the back to the pubic bone in front. The pelvic floor muscles support the bladder and bowel. The urethra (urine tube) and rectum (anus) pass through the pelvic floor muscles.
Prognosis - The likely outcome of a person’s disease.
Prostate cancer - Cancer of the prostate, the male organ that sits next to the urinary bladder and contributes to semen (sperm fluid) production.
Prostate gland - The prostate gland is normally the size of a walnut. It is located between the bladder and the penis and sits in front of the rectum. It produces fluid that forms part of semen.
Prostate specific antigen (PSA) - A protein produced by cells in the prostate gland, which is usually found in the blood in larger than normal amounts when prostate cancer is present.
Quality of life - An individual’s overall appraisal of their situation and wellbeing. Quality of life encompasses symptoms of disease and side effects of treatment, functional capacity, social interactions and relationships, and occupational functioning.
Radical prostatectomy - A surgical operation that removes the prostate.
Radiotherapy or radiation oncology - The use of radiation, usually x-rays or gamma rays, to kill tumour cells or injure them so they cannot grow or multiply.
Self-management - An awareness and active participation by people with cancer in their recovery, recuperation, and rehabilitation, to minimise the consequences of treatment, promote survival, health and wellbeing.
Shared decision making - Integration of a patient’s values, goals and concerns with the best available evidence about benefits, risks and uncertainties of treatment, in order to achieve appropriate health care decisions. It involves clinicians and patients making decisions about the patient’s management together.
Side effect - Unintended effects of a drug or treatment.
Stage - The extent of a cancer and whether the disease has spread from an original site to other parts of the body.
Standard treatment - The best proven treatment, based on results of past research.
Support group - People on whom an individual can rely for the provision of emotional caring and concern, and reinforcement of a sense of personal worth and value. Other components of support may include provision of practical or material aid, information, guidance, feedback and validation of the individual’s stressful experiences and coping choices.
Supportive care - Improving quality of life for people with cancer from different perspectives, including physical, social, emotional, financial and spiritual.
Survivorship - In cancer, survivorship focuses on the health and life of a person with cancer beyond the diagnosis and treatment phases. Survivorship includes issues related to follow-up care, late effects of treatment, second cancers, and quality of life.
Testosterone - The major male hormone which is produced by the testicles.
Urethra - The tube that carries urine from the bladder, and semen, out through the penis and to the outside of the body.
Abrahamsson, O.A. (2010). Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. European Urology, 57(1), 49-59.
Cancer Council Australia. (2009). Advanced prostate cancer – a guide for men and their families.
Cancer Council Australia. (2010). Localised prostate cancer – a guide for men and their families.
Centres for Disease Control and Prevention’s National Centre for Health Statistics. Calcium and Vitamin D: Important at Every Age.
Dennis, L. K., & Hayes, R. B. (2001). Alcohol and prostate cancer. Epidemiologic Reviews, 23(1), 110-114.
Gomella, L. G., Singh, J., Lallas, C., & Trabulsi, E. J. (2010). Hormone therapy in the management of prostate cancer: evidence-based approaches. Therapeutic Advances in Urology, 2(4), 171-181.
Guise, T. A., Oefelein, M.G., & Smith. M.R. (2007) Estrogenic side effects of androgen deprivation therapy. Reviews in Urology, 9(4), 163-180.
Hollenbach, K. A., Barrett- Connor, E., Edelstein, S. L., & Holbrook, T. (1993). Cigarette smoking and bone mineral density in older men and women. American Journal of Public Health, 83(9), 1265 - 1270.
National Health and Medical Research Council. (2013). Australian Dietary Guidelines. Canberra: National Health and Medical Research Council.
Prostate Cancer UK. Living with hormone therapy. A guide for men with prostate cancer.
Rashid, P. (2006). Your guide to prostate cancer, the disease, treatment options and outcomes, (2nd edition) Port Macquarie: Uronorth Group.
Saad, F. (2012). Breakthrough in advanced disease. Our Voice, 17(1), 14-16.
The SA Prostate Cancer Clinical Outcomes Collaborative (SAPCOCC). What does hormone treatment involve?
Zuccolo, L., Lewis, S.J., Donovan, J.L., Hamdy, F.C., Neal, D.E., & Smith, G.D. (2013). Alcohol consumption and PSA-detected prostate cancer risk – a case-control nested in the ProtecT study. International Journal of Cancer, 132(9), 2176-2185.